These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Growth factors in the regulation of plasminogen-plasmin system in tumor cells. Keski-Oja J; Koli K; Lohi J; Laiho M Semin Thromb Hemost; 1991 Jul; 17(3):231-9. PubMed ID: 1839081 [TBL] [Abstract][Full Text] [Related]
27. Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression. DeClerck YA; Laug WE Enzyme Protein; 1996; 49(1-3):72-84. PubMed ID: 8796998 [TBL] [Abstract][Full Text] [Related]
28. A novel assay to evaluate promoting effects of proteins on calcium oxalate crystal invasion through extracellular matrix based on plasminogen/plasmin activity. Chiangjong W; Thongboonkerd V Talanta; 2012 Nov; 101():240-5. PubMed ID: 23158318 [TBL] [Abstract][Full Text] [Related]
29. Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extracellular matrix. Lähteenmäki K; Virkola R; Pouttu R; Kuusela P; Kukkonen M; Korhonen TK Infect Immun; 1995 Sep; 63(9):3659-64. PubMed ID: 7642304 [TBL] [Abstract][Full Text] [Related]
30. [Clinical and etiopathogenetic role of plasminogen and metaloproteinase systems in the tumor growth. Pericellular proteolysis of extracellular matrix and tumor growth]. Cosić SJ; Kovac Z Lijec Vjesn; 2011; 133(1-2):56-63. PubMed ID: 21644280 [TBL] [Abstract][Full Text] [Related]
31. The PA-plasmin system during murine embryogenesis. Sappino AP; Wohlwend A; Huarte J; Belin D; Vassalli JD Ann N Y Acad Sci; 1992 Dec; 667():41. PubMed ID: 1309061 [No Abstract] [Full Text] [Related]
32. Plasminogen and plasminogen activator assembly on the human endothelial cell. Shih GC; Hajjar KA Proc Soc Exp Biol Med; 1993 Mar; 202(3):258-64. PubMed ID: 8437979 [TBL] [Abstract][Full Text] [Related]
33. Role of plasminogen activator-plasmin system in tumor angiogenesis. Rakic JM; Maillard C; Jost M; Bajou K; Masson V; Devy L; Lambert V; Foidart JM; Noël A Cell Mol Life Sci; 2003 Mar; 60(3):463-73. PubMed ID: 12737307 [TBL] [Abstract][Full Text] [Related]
34. Evidence for an extracellular plasmin-dependent proteolytic system in mineralizing matrices. Robinson RM; Taylor RE; Birkedal-Hansen H Calcif Tissue Int; 1984 Jan; 36(1):31-8. PubMed ID: 6231085 [TBL] [Abstract][Full Text] [Related]
36. Plasmin-mediated release of the guidance molecule F-spondin from the extracellular matrix. Tzarfaty-Majar V; López-Alemany R; Feinstein Y; Gombau L; Goldshmidt O; Soriano E; Muñoz-Cánoves P; Klar A J Biol Chem; 2001 Jul; 276(30):28233-41. PubMed ID: 11359777 [TBL] [Abstract][Full Text] [Related]
37. Plasminogen activator and protease inhibitor activities in isolated rat thymocytes. Mayer M; Finci Z; Kanaany J; Kaiser N Mol Cell Biochem; 1985 Mar; 66(2):137-44. PubMed ID: 3157048 [TBL] [Abstract][Full Text] [Related]
38. Fibrinolytic pathways and the endothelium. Hekman CM; Loskutoff DJ Semin Thromb Hemost; 1987 Oct; 13(4):514-27. PubMed ID: 2827312 [No Abstract] [Full Text] [Related]
39. Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues. ASTRUP T; ALBRECHTSEN OK Scand J Clin Lab Invest; 1957; 9(3):233-43. PubMed ID: 13495339 [No Abstract] [Full Text] [Related]
40. The content of plasminogen activator in the human urinary tract. LADEHOFF AA Scand J Clin Lab Invest; 1960; 12():136-9. PubMed ID: 14413370 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]